Log in
Enquire now
Orchard Therapeutics

Orchard Therapeutics

Orchard Therapeutics is a biotechnology company developing gene therapies for rare diseases.

OverviewStructured DataIssuesContributors

Contents

orchard-tx.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Tissue engineering
Tissue engineering
Stem cell
Stem cell
Healthcare
Healthcare
Immunotherapy
Immunotherapy
Stem-cell therapy
Stem-cell therapy
Cell therapy
Cell therapy
Gene therapy
Gene therapy
...
Location
United Kingdom
United Kingdom
United States
United States
London
London
0
Boston
Boston
0
San Francisco
San Francisco
B2X
B2B
B2B
CEO
Bobby Gaspar
Bobby Gaspar
0
Founder
Bobby Gaspar
Bobby Gaspar
Andrea Spezzi
Andrea Spezzi
0
Ben Auspitz
Ben Auspitz
0
Pitchbook URL
pitchbook.com/profiles...158081-41
Legal Name
Orchard Therapeutics, plc
Legal classification
Public limited company
Public limited company
Date Incorporated
2015
Spun Out From
UCL Business Ltd
UCL Business Ltd
Number of Employees (Ranges)
51 – 200
Email Address
info@orchard-tx.com0
business.development@orchard-tx.com0
patient.advocacy@orchard-tx.com0
medinfo@orchard-tx.com0
media@orchard-tx.com0
investors@orchard-tx.com0
drugsafety@orchard-tx.com0
Phone Number
+4420380882860
Number of Employees
180
Full Address
101 Seaport Boulevard, 7th Floor Boston, MA 02210 United States0
108 CANNON STREET, LONDON, United Kingdom, EC4N 6EU0
CIK Number
1,748,9070
Place of Incorporation
United Kingdom
United Kingdom
0
Investors
Temasek Holdings
Temasek Holdings
F-Prime Capital Partners
F-Prime Capital Partners
Deerfield Capital Management
Deerfield Capital Management
Agent Capital
Agent Capital
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine
‌
Avidity Partners
UCL Technology Fund
UCL Technology Fund
Driehaus Capital Management
Driehaus Capital Management
...
Founded Date
2015
Total Funding Amount (USD)
459,660,000
Latest Funding Round Date
February 5, 2021
Stock Symbol
ORTX0
Exchange
Nasdaq
Nasdaq
Board of Directors
Alicia Secor
Alicia Secor
0
‌
Charles Rowland
0
‌
Jim Geraghty
0
Marc Dunoyer
Marc Dunoyer
0
‌
John Curnutte
0
‌
Joanne Beck
0
‌
Steven Altschuler
0
Bobby Gaspar
Bobby Gaspar
0
CTO
‌
Nicoletta Loggia
0
Latest Funding Type
Series C
Series C
Country
United Kingdom
United Kingdom
0
United States
United States
0

Other attributes

Company Operating Status
Active
Latest Funding Round Amount (USD)
150,000,000
Previous Name
Orchard Rx Ltd0
SIC Code
2,8360
Ticker Symbol
ORTX0
Wikidata ID
Q107364296

Orchard Therapeutics is a biotechnology company developing gene therapies for patients with rare diseases. The company has a portfolio of approved ex vivo gene therapies.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Orchard Therapeutics Announces the Build-out of New Gene Therapy Manufacturing Facility in California

Orchard Therapeutics

https://www.globenewswire.com/news-release/2018/12/13/1666537/0/en/Orchard-Therapeutics-Announces-the-Build-out-of-New-Gene-Therapy-Manufacturing-Facility-in-California.html

Web

References

Find more companies like Orchard Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.